Orgenesis Inc. (ORGS)

USD 2.4

(10.6%)

Inventory Summary of Orgenesis Inc.

  • Orgenesis Inc.'s latest annual inventory in 2023 was 34 Thousand USD , down -71.67% from previous year.
  • Orgenesis Inc.'s latest quarterly inventory in 2024 Q2 was 1.00 USD , down -100.0% from previous quarter.
  • Orgenesis Inc. reported annual inventory of 120 Thousand USD in 2022, up 1.69% from previous year.
  • Orgenesis Inc. reported annual inventory of 118 Thousand USD in 2021, down -36.22% from previous year.
  • Orgenesis Inc. reported quarterly inventory of 34 Thousand USD for 2024 Q1, down 0.0% from previous quarter.
  • Orgenesis Inc. reported quarterly inventory of 128 Thousand USD for 2023 Q1, up 6.67% from previous quarter.

Annual Inventory Chart of Orgenesis Inc. (2023 - 2008)

Historical Annual Inventory of Orgenesis Inc. (2023 - 2008)

Year Inventory Inventory Growth
2023 34 Thousand USD -71.67%
2022 120 Thousand USD 1.69%
2021 118 Thousand USD -36.22%
2020 185 Thousand USD -90.94%
2019 2.04 Million USD 17.68%
2018 1.73 Million USD 139.45%
2017 725 Thousand USD 81.25%
2016 400 Thousand USD 32.89%
2015 301 Thousand USD 0.0%
2014 - USD 100.0%
2013 -36.9 Thousand USD -388.16%
2012 12.8 Thousand USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%

Peer Inventory Comparison of Orgenesis Inc.

Name Inventory Inventory Difference
America Great Health 108.35 Thousand USD 68.621%
Ampio Pharmaceuticals, Inc. 1.00 USD -3399900.0%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. - USD -Infinity%
Bio-Path Holdings, Inc. 632.00 USD -5279.747%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 2.5 Million USD 98.645%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. - USD -Infinity%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Molecular Templates, Inc. - USD -Infinity%
Navidea Biopharmaceuticals, Inc. 427.34 Thousand USD 92.044%
NexImmune, Inc. - USD -Infinity%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 9.97 Million USD 99.659%
Statera Biopharma, Inc. 1.8 Million USD 98.119%
TRACON Pharmaceuticals, Inc. - USD -Infinity%
Trevena, Inc. - USD -Infinity%
Vaxxinity, Inc. - USD -Infinity%
Vaccinex, Inc. - USD -Infinity%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. - USD -Infinity%